Randy Thurman, Director at Veradigm, holds 0.00 shares in TFF Pharmaceuticals (Ticker: TFFP), holds 11.88K shares in Outlook Therapeutics (Ticker: OTLK), holds 73.12K shares in Veradigm (Ticker: MDRX). Most recently, Randy Thurman Sold ― shares of TFF Pharmaceuticals on Sep 30, 2022 for an estimated value of 172.69K.